Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gastric carcinoma.

Alexandria T Phan1, Jaffer A Ajani

  • 1University of Texas MD Anderson Cancer Center, GI Medical Oncology Department, 1515 Holcombe Boulevard, Mailbox 426, Houston, TX 77030, USA. aphan@mdanderson.org

Current Oncology Reports
|April 7, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment Patterns of Long-Acting Somatostatin Analogs for Neuroendocrine Tumors.

Journal of health economics and outcomes research·2023
Same author

Neuroendocrine Tumors: a Relevant Clinical Update.

Current oncology reports·2022
Same author

Lanreotide autogel/depot in advanced enteropancreatic neuroendocrine tumours: final results of the CLARINET open-label extension study.

Endocrine·2020
Same author

YAP1 mediates gastric adenocarcinoma peritoneal metastases that are attenuated by YAP1 inhibition.

Gut·2020
Same author

Preoperative Chemoradiation Versus Chemotherapy in Gastroesophageal Junction Adenocarcinoma.

The Annals of thoracic surgery·2020
Same author

Cloning of ground-state intestinal stem cells from endoscopic biopsy samples.

Nature protocols·2020
Same journal

Revisiting the Immunological Landscape of Locoregional Therapies for Gastrointestinal Cancers: A Shift Toward Interventional Immuno-Oncology.

Current oncology reports·2026
Same journal

Anti-PD-1 Combinations: Triplets and Beyond.

Current oncology reports·2026
Same journal

Sacituzumab Tirumotecan Across Gynecologic Malignancies: One Target, Multiple Diseases.

Current oncology reports·2026
Same journal

Clusterin in Head and Neck Squamous Cell Carcinoma: Diagnostic, Prognostic, and Therapeutic Implications.

Current oncology reports·2026
Same journal

Cardiac Risk Without a Roadmap: Lack of Evidence-Based Guidance for Cardiovascular Toxicity of T-Cell Redirecting Therapies.

Current oncology reports·2026
Same journal

Current Understanding of CHIP's Immunobiological Footprint with A Focus on Gastrointestinal Disorders: A Review of the Literature.

Current oncology reports·2026
See all related articles

Gastric cancer remains a global health issue with limited survival improvements despite advances. Current US treatment for localized gastric cancer involves adjuvant chemoradiotherapy, with this review summarizing key clinical trials.

Area of Science:

  • Oncology
  • Gastroenterology
  • Clinical Trials

Background:

  • Gastric cancer is a significant global public health concern, though less common in Western nations.
  • Despite surgical, chemotherapy, and radiotherapy advancements, gastric cancer survival rates have stagnated.
  • Adjuvant chemoradiotherapy is the standard of care for localized, resectable gastric cancer in the US.

Purpose of the Study:

  • To summarize pivotal randomized and phase II/III clinical trials in gastric cancer treatment.
  • To provide an overview of current therapeutic strategies for gastric cancer.
  • To highlight advancements and persistent challenges in managing gastric cancer.

Main Methods:

  • Review of salient randomized clinical trials.
  • Analysis of phase II and III clinical trial data.

Related Experiment Videos

  • Synthesis of current treatment paradigms for gastric cancer.

    • Main Results:

    • The article summarizes key findings from major clinical trials in gastric cancer.
    • It highlights the current standard of care, including adjuvant chemoradiotherapy.
    • The review underscores the lack of significant survival improvement over recent decades.

    Conclusions:

    • Gastric cancer treatment remains challenging, with limited progress in survival rates.
    • Adjuvant chemoradiotherapy is a cornerstone of current US treatment protocols for resectable disease.
    • Further research and clinical trials are essential to improve outcomes for gastric cancer patients.